Income Statement Wellell Inc.

Stocks

4106

TW0004106000

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. 2026-08-14			5-day change	1st Jan Change
24.65 ^TWD	-0.40%		+0.20%	+11.79%

08-04	Wellell Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-10	Wellell to Merge Units to Streamline German Operations	MT

44ae7329fc4ee3781c2b03.lf5heDTiwcEJQ7jsFq6jvgKCoPoEz33Jp7TAlV4GEko.3JBWAFqF9_IwHP-8Rujk9FH6xKJ1uzCr_vanzDBAeTilqCkzTdCu9E457Q

Published financial data: WELLELL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2.37B	2.66B	2.65B	2.39B	2.4B
Total Revenues	2.37B	2.66B	2.65B	2.39B	2.4B
Cost of Goods Sold, Total	1.39B	1.6B	1.51B	1.31B	1.3B
Gross Profit	987M	1.07B	1.14B	1.07B	1.1B
Selling General & Admin Expenses, Total	732M	726M	778M	765M	791M
Provision for Bad Debts	-316K	1.18M	-159K	14.74M	8.24M
R&D Expenses	151M	154M	166M	164M	154M
Other Operating Expenses, Total	883M	882M	944M	943M	953M
Operating Income	104M	185M	194M	132M	151M
Interest Expense, Total	-7.67M	-10.18M	-14.18M	-12.95M	-10.18M
Interest And Investment Income	2.86M	3.1M	6.21M	9.29M	6.53M
Net Interest Expenses	-4.81M	-7.08M	-7.97M	-3.66M	-3.64M
Income (Loss) On Equity Invest.	-	-	-323K	-1.16M	-1.13M
Currency Exchange Gains (Loss)	-653K	-6.11M	2.57M	-1.86M	12.66M
Other Non Operating Income (Expenses)	30.32M	28.91M	34.23M	23.68M	8.37M
EBT, Excl. Unusual Items	129M	201M	223M	149M	167M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-8.03M	-	-
Gain (Loss) On Sale Of Investments	38K	-	-	-	-
Gain (Loss) On Sale Of Assets	-397K	-121K	-452K	-860K	-592K
Asset Writedown	-	-	-4.39M	-	-
Other Unusual Items	9.26M	-	-	-	-
EBT, Incl. Unusual Items	138M	201M	210M	148M	166M
Income Tax Expense	34.57M	38.42M	56.84M	32.19M	44.68M
Earnings From Continuing Operations	104M	162M	153M	116M	122M
Net Income to Company	104M	162M	153M	116M	122M
Minority Interest	-1.26M	-705K	-840K	-412K	-693K
Net Income - (IS)	102M	161M	152M	115M	121M
Net Income to Common Incl Extra Items	102M	161M	152M	115M	121M
Net Income to Common Excl. Extra Items	102M	161M	152M	115M	121M
Per Share Items
Net EPS - Basic	1.01	1.6	1.51	1.14	1.2
Basic EPS - Continuing Operations	1.01	1.6	1.51	1.14	1.2
Basic Weighted Average Shares Outstanding	101M	101M	101M	101M	101M
Net EPS - Diluted	1.01	1.59	1.5	1.14	1.19
Diluted EPS - Continuing Operations	1.01	1.59	1.5	1.14	1.19
Diluted Weighted Average Shares Outstanding	101M	102M	102M	101M	102M
Normalized Basic EPS	0.79	1.24	1.37	0.92	1.03
Normalized Diluted EPS	0.78	1.23	1.36	0.91	1.02
Dividend Per Share	0.55	0.85	0.8	0.8	-
Payout Ratio	54.28	34.39	56.37	70.05	66.65
Supplemental Items
EBITDA	196M	276M	285M	223M	251M
EBITA	121M	200M	212M	147M	166M
EBIT	104M	185M	194M	132M	151M
EBITDAR	218M	-	309M	256M	283M
Effective Tax Rate - (Ratio)	25.04	19.16	27.09	21.77	26.83
Total Current Taxes	30.69M	36.66M	53.24M	36.45M	46.84M
Total Deferred Taxes	3.88M	1.76M	3.6M	-4.26M	-2.16M
Normalized Net Income	79.47M	125M	138M	92.53M	104M
Interest on Long-Term Debt	961K	821K	910K	763K	489K
Non-Cash Pension Expense	39K	25K	-48K	-175K	-35K
Supplemental Operating Expense Items
Selling and Marketing Expenses	369M	379M	379M	390M	394M
General and Administrative Expenses	363M	347M	399M	375M	396M
Research And Development Expense From Footnotes	151M	154M	166M	164M	154M
Net Rental Expense, Total	22.24M	-	24.56M	32.26M	31.81M
Imputed Operating Lease Interest Expense	2.79M	-	6.56M	9.94M	9.3M
Imputed Operating Lease Depreciation	19.44M	-	18M	22.32M	22.51M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	493M	445M	648M	666M	785M
Short Term Investments	106M	90.16M	111M	116M	53.96M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	599M	535M	759M	783M	839M
Accounts Receivable, Total	372M	508M	491M	382M	395M
Other Receivables	23.05M	29.12M	27.23M	16.66M	7.67M
Total Receivables	395M	537M	518M	399M	402M
Inventory	557M	553M	420M	416M	424M
Prepaid Expenses	34.93M	36.1M	23.9M	31.42M	-
Other Current Assets, Total	2.07M	16.14M	799K	15.67M	32.89M
Total Current Assets	1.59B	1.68B	1.72B	1.64B	1.7B
Gross Property Plant And Equipment	1.24B	1.27B	1.27B	1.33B	1.35B
Accumulated Depreciation	-432M	-469M	-506M	-565M	-605M
Net Property Plant And Equipment	805M	804M	765M	762M	746M
Long-term Investments	15.87M	19.16M	24M	22.1M	18.1M
Goodwill	505M	503M	514M	531M	541M
Other Intangibles, Total	163M	147M	135M	126M	122M
Deferred Tax Assets Long-Term	32.63M	30.28M	34.48M	37.02M	37.04M
Other Long-Term Assets, Total	30.72M	16.63M	30.05M	14.68M	16.26M
Total Assets	3.14B	3.2B	3.22B	3.14B	3.18B
Liabilities
Accounts Payable, Total	206M	175M	179M	134M	118M
Accrued Expenses, Total	1.31M	30K	50K	-	-
Short-term Borrowings	352M	295M	196M	156M	119M
Current Portion of Long-Term Debt	16.27M	10.26M	11.97M	11.19M	8.54M
Current Portion of Leases	12.81M	16.15M	15.62M	18.96M	19.71M
Current Income Taxes Payable	18.22M	33.54M	43.66M	22.1M	33.08M
Other Current Liabilities	267M	241M	253M	241M	244M
Total Current Liabilities	874M	771M	699M	584M	542M
Long-Term Debt	122M	121M	113M	103M	93.93M
Long-Term Leases	42.38M	42.4M	28.19M	18.74M	7.61M
Pension & Other Post Retirement Benefits	5.36M	1.04M	738K	-	-
Deferred Tax Liability Non Current	36K	290K	7.92M	6.82M	4.93M
Other Non Current Liabilities	32.25M	33.96M	35.29M	1.55M	-
Total Liabilities	1.08B	970M	884M	714M	648M
Common Stock, Total	1.01B	1.01B	1.01B	1.01B	1.01B
Additional Paid In Capital	346M	346M	346M	346M	346M
Retained Earnings	957M	1.07B	1.13B	1.17B	1.21B
Comprehensive Income and Other	-253M	-200M	-152M	-107M	-36.55M
Total Common Equity	2.06B	2.22B	2.34B	2.42B	2.53B
Minority Interest	5.19M	6.29M	4.89M	5.65M	302K
Total Equity	2.06B	2.23B	2.34B	2.42B	2.53B
Total Liabilities And Equity	3.14B	3.2B	3.22B	3.14B	3.18B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	101M	101M	101M	101M	101M
ECS Total Common Shares Outstanding	101M	101M	101M	101M	101M
Book Value / Share	20.4	22.01	23.15	23.96	25.07
Tangible Book Value	1.39B	1.57B	1.69B	1.76B	1.87B
Tangible Book Value Per Share	13.78	15.56	16.72	17.45	18.5
Total Debt	546M	485M	365M	308M	248M
Net Debt	-52.8M	-50.01M	-395M	-475M	-590M
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.36M	1.04M	738K	-2.51M	-3.78M
Debt Equivalent Oper. Leases	178M	-	197M	258M	254M
Minority Interest, Total (Incl. Fin. Div)	5.19M	6.29M	4.89M	5.65M	302K
Equity Method Investments, Total	-	-	2.88M	1.62M	446K
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	139M	115M	62.47M	53.11M	49.64M
Inventories - Work In Process, Total	102M	98.36M	57.44M	39.53M	57.31M
Inventories - Finished Goods, Total	317M	339M	300M	323M	317M
Land - (BS)	278M	279M	280M	281M	283M
Buildings, Total	648M	661M	671M	682M	736M
Machinery, Total	68.76M	77.17M	268M	318M	95.97M
Accumulated Allowance for Doubtful Accounts (Supple)	6.11M	7.12M	6.84M	21.48M	27.71M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	102M	161M	152M	115M	121M
Depreciation & Amortization - CF	74.98M	75.38M	73.03M	75.98M	84.62M
Amortization of Goodwill and Intangible Assets - (CF)	16.23M	15.26M	17.59M	15.65M	15.33M
Depreciation & Amortization, Total	91.21M	90.64M	90.62M	91.62M	99.95M
Amortization of Deferred Charges, Total - (CF)	2.34M	2.67M	3.14M	3.59M	3.83M
(Gain) Loss From Sale Of Asset	397K	121K	452K	860K	592K
(Gain) Loss on Sale of Investments - (CF)	-38K	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	12.42M	-	-
(Income) Loss On Equity Investments - (CF)	-	-	323K	1.16M	1.13M
Provision and Write-off of Bad Debts	-316K	1.18M	-159K	14.74M	8.24M
Other Operating Activities, Total	984K	24.08M	17.08M	-25.55M	10.58M
Change in Trading Asset Securities	-	-	-	-	-
Change In Accounts Receivable	-52.61M	-138M	20.02M	84.72M	-23.2M
Change In Inventories	-181M	2.39M	132M	4.49M	-8.5M
Change In Accounts Payable	85.04M	-31.13M	17.56M	-44.67M	-15.96M
Change in Other Net Operating Assets	-29.66M	-31.65M	9.81M	-32.97M	9.68M
Cash from Operations	19M	82.14M	456M	213M	207M
Capital Expenditure	-46.67M	-44.99M	-28.83M	-56.91M	-47.05M
Sale of Property, Plant, and Equipment	2.61M	577K	1.6M	1.73M	2.02M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-5.62M	-3M	-3.28M	-3.82M	-5.72M
Investment in Marketable and Equity Securities, Total	32.75M	15.42M	-23.96M	-5.4M	77.37M
Other Investing Activities, Total	1.01M	-911K	1.58M	2.88M	-300K
Cash from Investing	-15.92M	-32.9M	-52.9M	-61.53M	26.33M
Short Term Debt Issued, Total	996M	1.26B	665M	575M	621M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	996M	1.26B	665M	575M	621M
Short Term Debt Repaid, Total	-825M	-1.33B	-755M	-616M	-662M
Long-Term Debt Repaid, Total	-34.4M	-24.46M	-24.4M	-31.24M	-42.53M
Total Debt Repaid	-859M	-1.35B	-779M	-648M	-705M
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-55.5M	-55.5M	-85.78M	-80.73M	-80.73M
Common & Preferred Stock Dividends Paid	-55.5M	-55.5M	-85.78M	-80.73M	-80.73M
Other Financing Activities, Total	-	-	-	101K	-
Cash from Financing	81.88M	-146M	-200M	-153M	-164M
Foreign Exchange Rate Adjustments	-61.89M	48.64M	717K	19.34M	48.81M
Net Change in Cash	23.07M	-47.95M	203M	18.06M	118M
Supplemental Items
Cash Interest Paid	7.56M	9.83M	14.06M	13.48M	14.05M
Cash Income Tax Paid (Refund)	37.97M	18.14M	41.43M	57.76M	35.26M
Levered Free Cash Flow	-113M	-41.3M	380M	132M	138M
Unlevered Free Cash Flow	-109M	-34.93M	388M	140M	145M
Change In Net Working Capital	215M	196M	-205M	-23.47M	718K
Net Debt Issued / Repaid	137M	-90.33M	-115M	-72.36M	-83.68M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.11	3.65	3.77	2.59	2.98
Return on Total Capital	2.53	4.34	4.48	3.03	3.42
Return On Equity %	4.96	7.55	6.7	4.85	4.92
Return on Common Equity	4.91	7.54	6.68	4.85	4.9
Margin Analysis
Gross Profit Margin %	41.57	40.05	43	45.04	45.9
SG&A Margin	30.84	27.27	29.41	32.05	32.89
EBITDA Margin %	8.24	10.35	10.76	9.36	10.43
EBITA Margin %	5.08	7.52	8	6.17	6.91
EBIT Margin %	4.39	6.94	7.34	5.52	6.27
Income From Continuing Operations Margin %	4.36	6.09	5.78	4.85	5.07
Net Income Margin %	4.31	6.06	5.75	4.83	5.04
Net Avail. For Common Margin %	4.31	6.06	5.75	4.83	5.04
Normalized Net Income Margin	3.35	4.68	5.23	3.88	4.31
Levered Free Cash Flow Margin	-4.77	-1.55	14.34	5.54	5.75
Unlevered Free Cash Flow Margin	-4.57	-1.31	14.67	5.88	6.01
Asset Turnover
Asset Turnover	0.77	0.84	0.82	0.75	0.76
Fixed Assets Turnover	2.84	3.31	3.37	3.12	3.19
Receivables Turnover (Average Receivables)	6.92	6.05	5.3	5.47	6.19
Inventory Turnover (Average Inventory)	2.97	2.88	3.1	3.14	3.1
Short Term Liquidity
Current Ratio	1.82	2.18	2.46	2.81	3.13
Quick Ratio	1.14	1.39	1.83	2.02	2.29
Operating Cash Flow to Current Liabilities	0.02	0.11	0.65	0.37	0.38
Days Sales Outstanding (Average Receivables)	52.75	60.32	68.84	66.89	58.94
Days Outstanding Inventory (Average Inventory)	122.75	126.77	117.67	116.64	117.87
Average Days Payable Outstanding	38.01	43.63	46.94	43.85	35.21
Cash Conversion Cycle (Average Days)	137.49	143.46	139.57	139.67	141.6
Long Term Solvency
Total Debt/Equity	26.45	21.79	15.57	12.72	9.82
Total Debt / Total Capital	20.92	17.89	13.47	11.28	8.94
LT Debt/Equity	7.97	7.35	6.03	5.02	4.01
Long-Term Debt / Total Capital	6.31	6.03	5.22	4.46	3.65
Total Liabilities / Total Assets	34.27	30.34	27.41	22.76	20.4
EBIT / Interest Expense	13.6	18.16	13.69	10.17	14.82
EBITDA / Interest Expense	25.49	27.06	20.08	17.24	24.64
(EBITDA - Capex) / Interest Expense	19.41	22.64	18.05	12.85	20.02
Total Debt / EBITDA	2.79	1.76	1.28	1.38	0.99
Net Debt / EBITDA	-0.27	-0.18	-1.39	-2.12	-2.35
Total Debt / (EBITDA - Capex)	3.67	2.11	1.42	1.85	1.22
Net Debt / (EBITDA - Capex)	-0.35	-0.22	-1.54	-2.85	-2.9
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.46	12.2	-0.62	-9.84	0.74
Gross Profit, 1 Yr. Growth %	16.44	8.09	6.7	-5.58	2.67
EBITDA, 1 Yr. Growth %	11.24	40.94	3.36	-21.59	12.29
EBITA, 1 Yr. Growth %	14.39	66.07	5.8	-30.43	12.76
EBIT, 1 Yr. Growth %	5.44	77.28	5.02	-32.19	14.52
Earnings From Cont. Operations, 1 Yr. Growth %	-1.77	56.62	-5.61	-24.42	5.33
Net Income, 1 Yr. Growth %	-2.24	57.86	-5.72	-24.27	5.11
Normalized Net Income, 1 Yr. Growth %	3.47	56.92	10.95	-33.13	12.11
Diluted EPS Before Extra, 1 Yr. Growth %	-1.94	57.43	-5.66	-24	4.39
Accounts Receivable, 1 Yr. Growth %	18.65	36.43	-3.44	-22.16	3.35
Inventory, 1 Yr. Growth %	48	-0.77	-23.93	-1.07	2.04
Net Property, Plant and Equip., 1 Yr. Growth %	-7.04	-0.2	-4.74	-0.4	-2.14
Total Assets, 1 Yr. Growth %	3.09	1.81	0.55	-2.7	1.3
Tangible Book Value, 1 Yr. Growth %	-0.64	12.91	7.41	4.34	6.05
Common Equity, 1 Yr. Growth %	-2.03	7.87	5.16	3.51	4.63
Cash From Operations, 1 Yr. Growth %	-93.2	1.06K	454.7	-53.2	-2.71
Capital Expenditures, 1 Yr. Growth %	0.82	-3.6	-35.92	97.42	-17.33
Levered Free Cash Flow, 1 Yr. Growth %	-162.63	-63.57	-1.02K	-65.17	4.57
Unlevered Free Cash Flow, 1 Yr. Growth %	-158.12	-67.82	-1.21K	-63.88	3.07
Dividend Per Share, 1 Yr. Growth %	0	54.55	-5.88	0	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.98	15.29	5.59	-5.34	-4.7
Gross Profit, 2 Yr. CAGR %	7.51	12.19	7.39	0.38	-1.54
EBITDA, 2 Yr. CAGR %	-2.53	25.21	20.7	-9.98	-6.17
EBITA, 2 Yr. CAGR %	-3.87	37.83	32.55	-14.21	-11.43
EBIT, 2 Yr. CAGR %	-9.99	36.72	36.44	-15.61	-11.88
Earnings From Cont. Operations, 2 Yr. CAGR %	7.96	24.03	21.58	-15.54	-10.77
Net Income, 2 Yr. CAGR %	7.84	24.23	22	-15.5	-10.78
Normalized Net Income, 2 Yr. CAGR %	0.22	27.42	31.95	-13.86	-13.41
Diluted EPS Before Extra, 2 Yr. CAGR %	7.75	24.25	21.87	-15.33	-10.93
Accounts Receivable, 2 Yr. CAGR %	10.09	27.23	14.78	-13.3	-10.3
Inventory, 2 Yr. CAGR %	25.98	21.19	-13.12	-13.25	0.48
Net Property, Plant and Equip., 2 Yr. CAGR %	2.94	-3.68	-2.5	-2.59	-1.27
Total Assets, 2 Yr. CAGR %	1.97	2.45	1.34	-1.09	-0.72
Tangible Book Value, 2 Yr. CAGR %	-6.57	5.92	10.13	5.87	5.19
Common Equity, 2 Yr. CAGR %	0.81	2.8	6.51	4.33	4.07
Cash From Operations, 2 Yr. CAGR %	-66.92	-45.77	702.8	61.12	-32.53
Capital Expenditures, 2 Yr. CAGR %	22.95	-1.42	-21.41	12.47	27.75
Levered Free Cash Flow, 2 Yr. CAGR %	-3.78	-52.23	82.98	78.89	-39.65
Unlevered Free Cash Flow, 2 Yr. CAGR %	-9.88	-56.75	89.15	100.38	-38.99
Dividend Per Share, 2 Yr. CAGR %	10.55	24.32	20.6	-2.99	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.08	9.37	9.72	0.18	-3.36
Gross Profit, 3 Yr. CAGR %	4.02	7.71	10.33	2.88	1.14
EBITDA, 3 Yr. CAGR %	0.41	10.22	17.46	4.53	-3.09
EBITA, 3 Yr. CAGR %	-4.55	15.34	26.2	6.92	-6.02
EBIT, 3 Yr. CAGR %	-8.66	12.83	25.21	8.08	-6.57
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.8	22.22	13.24	3.77	-9.09
Net Income, 3 Yr. CAGR %	-1.93	22.45	13.31	4.07	-9.13
Normalized Net Income, 3 Yr. CAGR %	-5.31	16.37	21.68	5.2	-5.95
Diluted EPS Before Extra, 3 Yr. CAGR %	-4.89	22.26	13.35	4.12	-9.21
Accounts Receivable, 3 Yr. CAGR %	-0.66	18.25	16.05	0.84	-8.07
Inventory, 3 Yr. CAGR %	15.05	16.35	3.76	-9.27	-8.42
Net Property, Plant and Equip., 3 Yr. CAGR %	5.29	1.88	-4.03	-1.8	-2.44
Total Assets, 3 Yr. CAGR %	-0.06	1.92	1.92	-0.03	-0.3
Tangible Book Value, 3 Yr. CAGR %	-4.3	-0.48	6.42	8.17	5.93
Common Equity, 3 Yr. CAGR %	0.66	3.11	3.59	5.5	4.43
Cash From Operations, 3 Yr. CAGR %	-45.74	-22.08	17.72	211.28	36.18
Capital Expenditures, 3 Yr. CAGR %	-35.13	13.37	-14.6	6.84	1.5
Levered Free Cash Flow, 3 Yr. CAGR %	8.03	-30.39	28	5.25	49.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.99	-36.07	27.63	8.92	60.55
Dividend Per Share, 3 Yr. CAGR %	-5.42	23.61	13.3	13.3	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.59	4.98	4.68	3.23	3.71
Gross Profit, 5 Yr. CAGR %	2.36	3.31	5.36	4.71	5.42
EBITDA, 5 Yr. CAGR %	-4.48	4.15	8.08	1.65	7.37
EBITA, 5 Yr. CAGR %	-8.2	3.32	8.85	2.47	9.53
EBIT, 5 Yr. CAGR %	-8.12	3.74	7.24	0.45	8.8
Earnings From Cont. Operations, 5 Yr. CAGR %	-3.34	6.62	6.96	5.42	2.94
Net Income, 5 Yr. CAGR %	-3.55	6.42	7.02	5.56	2.98
Normalized Net Income, 5 Yr. CAGR %	-4.66	5.15	8.13	3.18	6.19
Diluted EPS Before Extra, 5 Yr. CAGR %	-6.92	3.53	5.03	5.55	2.93
Accounts Receivable, 5 Yr. CAGR %	6.07	9.2	5.25	4.44	4.69
Inventory, 5 Yr. CAGR %	12.15	9.44	2.83	3.46	2.44
Net Property, Plant and Equip., 5 Yr. CAGR %	5.26	6.61	2.1	0.07	-2.94
Total Assets, 5 Yr. CAGR %	3.92	4.35	0.5	0.77	0.85
Tangible Book Value, 5 Yr. CAGR %	4.39	6.23	1.23	2.01	5.92
Common Equity, 5 Yr. CAGR %	5.78	6.7	2.96	3.6	3.78
Cash From Operations, 5 Yr. CAGR %	-38.63	-14.35	30.81	4.2	-5.78
Capital Expenditures, 5 Yr. CAGR %	3.07	16.36	-29.95	13.01	0.33
Levered Free Cash Flow, 5 Yr. CAGR %	-9.2	-6.42	33.38	1.54	-5.25
Unlevered Free Cash Flow, 5 Yr. CAGR %	-10.46	-11.23	35.88	0.97	-5
Dividend Per Share, 5 Yr. CAGR %	-7.22	1.22	4.24	12.2	-